Premium
A PHASE 3 STUDY OF ACALABRUTINIB PLUS BENDAMUSTINE AND RITUXIMAB IN ELDERLY (AGED ≥65 Years) TREATMENT‐NAIVE PATIENTS WITH MANTLE CELL LYMPHOMA
Author(s) -
Wang M.,
Belada D.,
Cheah C.,
Chu M.P.,
Dreyling M.,
Flinn I.,
Fogliatto L.,
Goy A.,
Inwards D.,
Jurczak W.,
Mayer J.,
Re F.,
Robak T.,
Spurgeon S.,
Yoon S.S.,
Zinzani P.L.,
Yin M.,
Chen T.,
Kahl B.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2632
Subject(s) - mantle cell lymphoma , bendamustine , medicine , rituximab , gastroenterology , oncology , lymphoma
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom